MedPath

GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma

Phase 3
Completed
Conditions
Glaucoma
Interventions
Procedure: Cataract Surgery
Device: iStent Inject (GTS400)
Registration Number
NCT01052558
Lead Sponsor
Glaukos Corporation
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of the GTS400 trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hypertension and co-existing cataract.

Detailed Description

Glaucoma is a collection of disorders characterized by progressive loss of visual field due to optic nerve damage. It is a leading cause of blindness in the United States, affecting 1-2% of individuals aged 60 and over. Management of glaucoma requires chronic, life-long treatment with a spectrum of therapeutic options including medications, laser treatment and surgical implants. The common goal among the various therapies is to lower intraocular pressure to target levels in order to prevent loss of visual fields from excessive pressure on the optic nerve.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
164
Inclusion Criteria
  • Diagnosed with open-angle glaucoma in the study eye
  • Subject must be on 1 to 3 glaucoma medications
  • Subject able and willing to attend follow up visits for two years postop
  • Subject able and willing to sign informed consent
Exclusion Criteria
  • Pseudoexfoliative and pigmentary glaucoma
  • Prior glaucoma surgery of any type

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cataract Surgery OnlyCataract Surgery-
Treatment with Cataract Surgery & StentsiStent Inject (GTS400)Ab interno trabecular micro-bypass stent surgery
Primary Outcome Measures
NameTimeMethod
Proportion of subjects with 12 month diurnalIOP </= 21 mmHg without use of ocular hypotensive medications for >/= 4 weeks prior to 12 month visit.12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (22)

St. John's Medical Research Institute

🇺🇸

Springfield, Missouri, United States

Las Vegas Physician Research Group

🇺🇸

Henderson, Nevada, United States

Chicago Eye Specialists

🇺🇸

Chicago, Illinois, United States

Whitson Vision, PC

🇺🇸

Indianapolis, Indiana, United States

Ophthalmic Consultants of Long Island

🇺🇸

Rockville Center, New York, United States

Shepherd Eye Center

🇺🇸

Las Vegas, Nevada, United States

Thomas Mundorf, MD

🇺🇸

Charlotte, North Carolina, United States

Boozman-Hof Regional Eye Clinic

🇺🇸

Rogers, Arkansas, United States

North Bay Eye Associates, Inc.

🇺🇸

Petaluma, California, United States

The Center for Excellence in Eye Care

🇺🇸

Miami, Florida, United States

Laurel Eye Clinic

🇺🇸

Brookville, Pennsylvania, United States

Carolina Eyecare Physicians

🇺🇸

Mt. Pleasant, South Carolina, United States

Vance Thompson Vision / Sanford Clinic

🇺🇸

Sioux Falls, South Dakota, United States

Glaucoma Consultants of Colorado

🇺🇸

Parker, Colorado, United States

Texan Eye

🇺🇸

Austin, Texas, United States

Lehmann Eye Center

🇺🇸

Nacogdoches, Texas, United States

International Eye Center

🇺🇸

Tampa, Florida, United States

Clayton Eye Center / Eye Care Centers Management, Inc.

🇺🇸

Morrow, Georgia, United States

D'Ambrosio Eye Care

🇺🇸

Lancaster, Massachusetts, United States

Kresge Eye Institute

🇺🇸

Detroit, Michigan, United States

Discover Vision Centers

🇺🇸

Independence, Missouri, United States

Silverstein Eye Centers

🇺🇸

Kansas City, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath